Human growth hormone: the dilemma of expanded use in children

Area of Science:

• Pediatric Endocrinology
• Medical Ethics
• Clinical Research

Background:

• Human growth hormone (hGH) is used to treat children with growth hormone abnormalities.
• The application of hGH for short children without diagnosed deficiencies is a growing clinical practice.
• This practice raises significant ethical and clinical questions regarding treatment efficacy and patient well-being.

Purpose of the Study:

• To explore the ethical considerations surrounding the use of hGH in pediatric endocrinology.
• To examine the clinical reality and controversies of using hGH for short stature in children.
• To address the moral dilemmas in pediatric clinical research, particularly concerning placebo-controlled trials.

Main Methods:

• The study is primarily a review and ethical analysis of current clinical practices.
• It synthesizes existing literature and ethical frameworks related to hGH therapy in children.
• Discussion involves ethical quandaries in pediatric research and healthcare delivery.

Main Results:

• hGH treatment is generally effective for children with confirmed growth hormone deficiency based on established criteria.
• The use of hGH for short children without a diagnosed deficiency is ethically and clinically more controversial.
• There is an ongoing debate regarding the ethical conduct of clinical trials involving children, including the use of placebo arms.

Conclusions:

• The ethical justification for using hGH in children without diagnosed deficiencies requires careful consideration.
• Balancing the pursuit of knowledge through clinical trials with the ethical protection of pediatric participants remains a challenge.
• Defining short stature as a condition warranting medical intervention is a subject of ongoing ethical debate.